Skip to main content
. 2014 Aug 28;2014:569107. doi: 10.1155/2014/569107

Table 2.

Preoperative comorbidity of enrolled participants.

Preoperative comorbidity CFNB group PCIA group P value
n/N (%) n/N (%)
Cardiovascular system
 Hypertension 41/140 (34.2) 29/140 (24.2) 0.098
 Coronary artery disease 7/140 (5.8) 7/140 (5.8) 1.000
Arrhythmia
 Atrial fibrillation 1/140 (0.8) 1/140 (0.8) 1.000∗
 Ventricular premature 0/140 (0) 3/140 (2.5) 0.247∗
 Sinus bradycardia 0/140 (0) 2/140 (1.7) 0.498∗
Respiratory system
 Asthma 2/140 (1.7) 0/140 (0) 0.498∗
 COPD 4/140 (3.3) 8/140 (5.7) 0.238
 Respiratory failure 1/140 (0.8) 1/140 (0.8) 1.000∗
Urological system
 Renal syndrome 0/140 (0) 1/140 (0.8) 0.500∗
 Renal failure 0/140 (0) 1/140 (0.8) 0.500∗
Endocrine system and autoimmune disease
 Diabetes 18/140 (15) 9/140 (7.5) 0.068
 Rheumatoid arthritis 0/140 (0) 3/140 (2.1) 0.247∗
Thromboembolic events
 Cerebral embolism 2/140 (1.7) 0/140 (0) 0.498∗
 Myocardial infraction 0/140 (0) 0/140 (0)
 Venous thrombosis 0/140 (0) 2/140 (1.7) 0.498∗
 Peripheral artery embolism 0/140 (0) 0/140 (0)

Categorical variables as number of events (n), Chi square test was used; events less than 5 were compared with Fisher's exact test, *P < 0.05.